Simplifying Global Compliance
FDAnews Device Daily Bulletin
J&J Q3 Earnings Dip on Manufacturing Issues
Dec. 9, 2011
Diversion of resources from marketing and research to quality and manufacturing figured into a domestic sales slump and a 6 percent drop in earnings at Johnson & Johnson (J&J) in the third quarter from the same period in 2010.
The GMP Letter
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing